Table 2.
Association Between LDL Subfractions and Incident CVD and Severity of CVD
Author, Year (Reference) |
Cardiovascular Outcome |
Participants | Predictor | Mean Value |
P Value | Other Results | P Value | Adjusted for Lipids? |
Quality | |
---|---|---|---|---|---|---|---|---|---|---|
Persons With Event | Persons Without Event |
|||||||||
Incident CVD | ||||||||||
Cromwell et al, 2007 (13) | Incident CVD | 1440 men | LDL particle number | 1641 nmol/L | 1509 nmol/L | <0.001 | HR, 1.24 (95% CI, 1.10–1.39) per 1-SD increase in LDL particle number* | <0.001 | No | Fair |
1626 women | 1628 | 1344 | <0.001 | HR, 1.33 (95% CI, 1.17–1.50) per 1-SD increase in LDL particle number* | <0.001 | No | ||||
Event-free survival was higher in participants
with low LDL particle number, after dichotomization by LDL cholesterol level |
Yes | |||||||||
El Harchaoui et al, 2007 (14) | Fatal or nonfatal CAD |
1003 case patients, 1885 control participants |
Large (212–230 Å) Medium (no data on size) Small (180–212 Å) LDL particle number LDL particle size |
43 nmol/L 568 nmol/L 999 nmol/L 1640 nmol/L 210 Å |
36 nmol/L 572 nmol/L 885 nmol/L 1525 nmol/L 211 Å |
0.003
NS <0.001 <0.001 0.002 |
OR, 1.37 (95% CI, 1.04–1.83)† OR, 0.86 (95% CI, 0.65–1.15)‡ |
0.02 NS |
No No No Yes No |
Good |
Otvos et al, 2006 (15) | Nonfatal MI or cardiac death | 364 case patients, 697 control participants | Large (212–230 Å) | OR, 1.08 (95% CI, 0.95–1.23) per 1-SD increase§ |
NS | Yes∥ | Fair | |||
Small (180–212 Å) | OR, 1.11 (95% CI, 0.98–1.27) per 1-SD increase§ |
NS | Yes∥ | |||||||
LDL particle number | OR, 1.20 (95% CI, 1.05–1.37) per 1-SD increase§ |
<0.05 | Yes∥ | |||||||
LDL particle size | OR, 0.97 (95% CI, 0.85–1.10) per 1-SD increase§ |
NS | Yes∥ | |||||||
Kuller et al, 2002 (16) |
Incident MI or angina | Men: 243 case patients, 67 control participants | Large (213–230 Å) Medium (198–212 Å) Small (183–197 Å) LDL particle number LDL particle size |
57.3 mg/dL cholesterol 36 mg/dL cholesterol 25.7 mg/dL cholesterol 1676 nmol/L 209 Å |
58 mg/dL cholesterol 34.5 mg/dL cholesterol 22.7 mg/dL cholesterol 1597 nmol/L 210 Å |
NS NS NS NS NS |
No No No No No |
Fair | ||
Women: 191 case patients, 182 control participants |
Large (213–230 Å) Medium (198–212 Å) Small (183–197 Å) LDL particle number LDL particle size |
96 mg/dL cholesterol 8.2 mg/dL cholesterol 7.1 mg/dL cholesterol 1680 nmol/L 213 Å |
104 mg/dL cholesterol 6.8 mg/dL cholesterol 0 mg/dL cholesterol 1501 nmol/L 216 Å |
NS NS <0.05 <0.05 <0.05 |
OR, 1.77 (95% CI, 1.12–2.30), presence vs. absence of subfraction OR, 1.11 (95% CI, 1.03–1.09) per 100nmol/L increase¶ OR, 0.68 (95% CI, 0.51–0.91), unit of comparison not reported |
<0.05 <0.05 <0.05 |
No No Unclear Yes Unclear |
|||
Kuller et al, 2007 (17) | Cardiac death | 214 case patients, 214 control participants | Large (213–230 Å) Small (182–197 Å) LDL particle size |
500.7 nmol/L 1207.1 nmol/L No data |
465.8 nmol/L 1200.2 nmol/L No data |
NS NS NS |
ORs of quartiles and trend (no
data) ORs of quartiles and trend (no data) |
NS NS |
No No No |
Fair |
Hsia et al, 2008 (18) | ||||||||||
Substudy 1 | Incident MI, coronary death | 202 case patients, 200 control participants | LDL particle number | 1673 nmol/L | 1513 nmol/L | <0.001** | OR, 1.40 (95% CI, 1.08–1.83) per 1-SD increase†† | 0.01 | No | Fair |
Substudy 2 | Incident MI, coronary death | 149 case patients, 149 control participants | LDL particle number | 1687 nmol/L | 1525 nmol/L | <0.001 | OR, 1.31 (95% CI, 0.97–1.78) per 1-SD increase | 0.08 | No | Fair |
Blake et al, 2002 (19) | Cardiac death, incident MI, or stroke | 130 case patients, 130 control paraticipants | Large (213–227 Å) Medium (198–212 Å) Small (183–197 Å) LDL particle number LDL particle size |
886 nmol/L 201 nmol/L 0 1597 nmol/L 215 Å |
1001 nmol/L 126 nmol/L 0 1404 nmol/L 218 Å |
NS 0.008 NS <0.001 0.046 |
RR, 2.90 (95% CI, 1.16–7.30)‡‡ RR, 1.20 (95% CI, 0.51–2.82)‡‡ |
0.02 NS |
No No No Yes Yes |
Good |
Campbell et al, 2007 (20) | Intracerebral hemorrhage | 41 case patients, 107 control participants | Large (no data on size) Medium (no data on size) Small (no data on size) LDL particle number LDL particle size |
396 nmol/L 473 nmol/L 309 nmol/L 1461 nmol/L 208 Å |
252 nmol/L 473 nmol/L 377 nmol/L 1558 nmol/L |
0.03 NS NS NS |
OR, 1.18 (95% CI, 0.98–1.43) per
100-nmol/L increase§§ OR, 2.15 (95% CI, 0.97–4.78) per 10-Å increase§§ OR, 2.16 (95% CI, 0.97–4.80) per 10-Å increase∥∥ OR, 1.53 (95% CI, 0.55–4.30) per 10-Å increase¶¶ |
0.08 0.06 NS NS |
No No No No No Yes Yes |
Fair |
Soedamah-Muthu et al., 2003 (21) | Incident CAD | 59 case patients, 59 control participants | Large (213–230 Å) Medium (198–212 Å) Small (183–197 Å) LDL particle size |
603 nmol/L 120 nmol/L 800 nmol/L 206 Å |
688 nmol/L 111 nmol/L 526 nmol/L 210 Å |
NS ≤0.01 ≤0.001 ≤0.01 |
No data*** No data*** No data*** No data*** |
NS NS NS NS |
Yes Yes Yes Yes |
Fair |
CVD severity | ||||||||||
Rosenson et al, 2002 (22) | Change in MLD, mm MLD decrease >0.07 mm/y |
241 111 |
Large (213–230 Å) Small (183–197 Å) Large (213–230 Å) Small (183–197 Å) LDL particle number LDL particle size |
– – – – – – |
– – – – – – |
Spearman correlation, 0.03 Spearman correlation, −0.17††† OR, 0.4 (95% CI, 0.1–1.4) for <84 vs. ≥84 mg/dL OR, 9.1 (95% CI, 2.1–39) for <30 vs. ≥30 mg/dL OR, 1.4 (95% CI, 0.3–6.7) for <1825 vs. ≥1825 nmol/L OR, 0.2 (95% CI, 0.1–0.9) for <200 vs. ≥200 Å |
NS <0.01 NS <0.05 NS <0.05 |
Yes Yes Yes Yes Yes Yes |
Fair |
CAD coronary artery disease; CVD cardiovascular disease; HDL high-density lipoprotein; HR hazard ratio; LDL low-density lipoprotein; MI myocardial infarction; MLD minimum lumen diameter; NMR nuclear magnetic resonance; NS not statistically significant; OR odds ratio; RR risk ratio; Tg triglyceride.
Adjusted for age, systolic and diastolic blood pressure, smoking, and lipid medication use.
Adjusted for HDL cholesterol and Tg. Fourth quartile compared with first quartile.
Adjusted for LDL particle number. Fourth quartile compared with first quartile.
Adjusted for treatment group, age, hypertension, smoking, body mass index, and diabetes mellitus status.
Adjustment for LDL cholesterol, HDL cholesterol, and Tg did not “appreciably change these relations.”
Adjusted for age, race, and LDL cholesterol.
Adjusted for treatment group.
Adjusted for treatment group, age, smoking, alcohol use, diabetes, and hypertension.
Adjusted for Tg and total cholesterol/HDL cholesterol. Fourth quartile compared with first quartile.
Adjusted for matching factors.
Adjusted for total cholesterol level.
Adjusted for HDL cholesterol.
( Multivariable analysis with all predictors and Tg and HDL particle number.
Adjusted for LDL cholesterol, HDL cholesterol, Tg, and other factors.